Program of Applied Translational Research, Yale School of Medicine, New Haven, Connecticut; and.
Veterans Affairs Medical Center, Department of Medicine, West Haven, Connecticut.
Clin J Am Soc Nephrol. 2019 Jan 7;14(1):115-123. doi: 10.2215/CJN.13841217. Epub 2018 Apr 5.
Nephrotoxin-induced AKI is an iatrogenic form of AKI that can be potentially avoided or ameliorated by prompt recognition and appropriate prescriber actions. Drug-targeted alerts, either for patients at risk of AKI or patients with existing AKI, may lead to more appropriate drug dosing and management and improved clinical outcomes. However, alerts of this type are complicated to create, have a high potential for error and off-target effects, and may be difficult to evaluate. Although many studies have shown that these alerts can reduce the rate of inappropriate prescribing, few studies have examined the utility of such alerts in terms of patient benefit. In this review, we examine the current state of the literature in this area, identify key technical challenges, and suggest methods of evaluation for drug-targeted AKI alerts.
肾毒物引起的 AKI 是一种医源性 AKI,可以通过及时识别和适当的处方者行为来预防或减轻。针对有 AKI 风险的患者或已有 AKI 的患者的药物靶向警报,可能会导致更合适的药物剂量和管理,并改善临床结局。然而,此类警报的创建很复杂,存在很高的错误和脱靶效应的风险,并且可能难以评估。尽管许多研究表明这些警报可以降低不适当处方的发生率,但很少有研究从患者获益的角度来检查此类警报的效用。在这篇综述中,我们检查了该领域的现有文献,确定了关键的技术挑战,并提出了药物靶向 AKI 警报的评估方法。